Suppression studies in affective disorders.
D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D002395:Catecholamines / Q000378:metabolism; D003864:Depression, Chemical; D003907:Dexamethasone / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000652:urine; D007099:Imipramine / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales
D002395:Catecholamines; D010919:Placebos; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D007099:Imipramine; D006854:Hydrocortisone